Timing of allogeneic BMT for CML patients in India: Does it affect response?

被引:1
作者
Sazawal, Sudha [1 ]
Hasan, Syed Khizer
Kumar, Bijender
Kumar, Rajat
Kumar, Laut
Saxena, Renu
机构
[1] All India Inst Med Sci, Dept Haematol, New Delhi 29, India
[2] All India Inst Med Sci, Dept Med Oncol, New Delhi 29, India
关键词
D O I
10.1002/ajh.20767
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:329 / 329
页数:1
相关论文
共 3 条
[1]   Childhood CML in India: b2a2 transcript is more common than b3a2 [J].
Hasan, Syed Khizer ;
Sazawal, Sudha ;
Kumar, Bijender ;
Chaubey, Rekha ;
Mishra, Pravas ;
Mir, Rashid ;
Chaudhry, Ved Prakash ;
Saxena, Renu .
CANCER GENETICS AND CYTOGENETICS, 2006, 169 (01) :76-77
[2]   Unrelated donor marrow transplantation for chronic myelogenous leukemia: 9 years' experience of the National Marrow Donor Program [J].
McGlave, PB ;
Shu, XO ;
Wen, WQ ;
Anasetti, C ;
Nadermanee, A ;
Champlin, R ;
Antin, JH ;
Kernan, NA ;
King, R ;
Weisdorf, DJ .
BLOOD, 2000, 95 (07) :2219-2225
[3]   Allogeneic bone marrow transplantation for chronic myelogenous leukemia: comparative analysis of unrelated versus matched sibling donor transplantation [J].
Weisdorf, DJ ;
Anasetti, C ;
Antin, JH ;
Kernan, NA ;
Kollman, C ;
Snyder, D ;
Petersdorf, E ;
Nelson, G ;
McGlave, P .
BLOOD, 2002, 99 (06) :1971-1977